Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1980 2
1981 4
1982 3
1983 1
1984 1
1985 4
1986 6
1987 8
1988 6
1989 8
1990 2
1991 8
1992 4
1993 10
1994 14
1995 11
1996 7
1997 5
1998 4
1999 2
2000 6
2001 7
2002 5
2003 5
2004 1
2005 8
2006 14
2007 11
2008 17
2009 6
2010 5
2011 4
2012 7
2013 6
2014 8
2015 12
2016 8
2017 11
2018 11
2019 12
2020 10
2021 15
2022 16
2023 14
2024 23
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation.
Shimazu Y, Kanda J, Suzuki K, Wada A, Kikuchi T, Ikeda T, Tsukada N, Miwa A, Itagaki M, Kako S, Nishiwaki K, Ota S, Fujiwara SI, Kataoka K, Doki N, Sawa M, Hiramoto N, Nishikawa A, Imai T, Ichinohe T, Kanda Y, Atsuta Y, Kawamura K. Shimazu Y, et al. Among authors: tsukada n. Cancer Sci. 2024 Jul;115(7):2384-2395. doi: 10.1111/cas.16198. Epub 2024 May 16. Cancer Sci. 2024. PMID: 38757410 Free PMC article.
A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Quach H, Parmar G, Ocio EM, Prince HM, Oriol A, Crowther H, Tsukada N, Bories P, Madan S, Nathwani N, Sunami K, Semiond D, Yu D, Cordero P, Macé S, Suzan F, Moreau P. Quach H, et al. Among authors: tsukada n. Haematologica. 2024 Dec 1;109(12):4078-4082. doi: 10.3324/haematol.2023.284730. Haematologica. 2024. PMID: 39157871 Free PMC article. No abstract available.
Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis.
Suzuki K, Shimazu Y, Minakata D, Ikeda T, Takahashi H, Tsukada N, Kanda Y, Doki N, Nishiwaki K, Miwa A, Sawa M, Kataoka K, Hiramoto N, Ota S, Itagaki M, Ichinohe T, Atsuta Y, Yano S, Kawamura K; working group of the Japan Society for Transplantation and Cellular Therapy. Suzuki K, et al. Among authors: tsukada n. Transplant Cell Ther. 2023 Nov;29(11):688.e1-688.e13. doi: 10.1016/j.jtct.2023.08.006. Epub 2023 Aug 11. Transplant Cell Ther. 2023. PMID: 37574125 Free article.
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study.
Minakata D, Uchida T, Nakano A, Takase K, Tsukada N, Kosugi H, Kawata E, Nakane T, Takahashi H, Endo T, Nishiwaki S, Fujiwara H, Saito AM, Saito TI, Akashi K, Matsumura I, Mitani K. Minakata D, et al. Among authors: tsukada n. Int J Hematol. 2024 Feb;119(2):183-195. doi: 10.1007/s12185-023-03685-w. Epub 2024 Jan 3. Int J Hematol. 2024. PMID: 38172385 Free PMC article.
Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real-world clinical setting.
Kikuchi T, Tsukada N, Kunisada K, Matsumoto C, Nomura-Yogo M, Oda Y, Sato K, Takei T, Ogura M, Abe Y, Suzuki K, Hosoya O, Ishida T. Kikuchi T, et al. Among authors: tsukada n. Hematol Oncol. 2024 Sep;42(5):e3306. doi: 10.1002/hon.3306. Hematol Oncol. 2024. PMID: 39120040 No abstract available.
321 results